Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study

被引：0

作者：

Menzies-Gow, Andrew ^{[1
]}

Corren, Jonathan ^{[2
]}

Bourdin, Arnaud ^{[3
]}

Chupp, Geoffrey ^{[4
]}

Israel, Elliot ^{[5
,6
]}

Griffiths, Janet ^{[7
]}

Hellqvist, Asa ^{[8
]}

Bowen, Karin ^{[9
]}

Kaur, Primal ^{[10
]}

Almqvist, Gun ^{[11
]}

Ponnarambil, Sandhia ^{[12
]}

Colice, Gene ^{[13
]}

机构：

[1] Royal Brompton Hosp, London, England

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] CHU Montpellier, Hop Arnaud Villeneuve, Montpellier, France

[4] Yale Sch Med, New Haven, CT USA

[5] Harvard Med Sch, Boston, MA 02115 USA

[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[7] AstraZeneca, Translat Sci & Expt Med, Res & Early Dev, Resp & Immunol,BioPharmaceut R&D, Gaithersburg, MD USA

[8] AstraZeneca, BioPharmaceut R&D, Biometr Late Resp & Immunol, Gothenburg, Sweden

[9] Astrazeneca, BioPharmaceuticals R&D, Biometr Late Resp & Immunol, Gaithersburg, MD USA

[10] Amgen Inc, Thousand Oaks, CA USA

[11] AstraZeneca, Late Resp & Immunol, BioPharmaceut R&D, Gothenburg, Sweden

[12] AstraZeneca, BioPharmaceut R&D, Late Resp & Immunol, Cambridge, England

[13] AstraZeneca, Resp & Immunol, BioPharmaceut R&D, Gaithersburg, MD USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2021年 / 147卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

L46

引用

页码：AB249 / AB249

页数：1

共 50 条

[21] Characteristics of Asthma Exacerbations That Required Hospitalization in Patients with Severe, Uncontrolled Asthma Receiving Tezepelumab Compared with Placebo: Results from the Phase 3 NAVIGATOR Study
Ambrose, C. S.
Cook, B.
Roseti, S. L.
Gelhorn, H.
Cutts, K.
Lindsley, A. W.
Colice, G.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[22] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
Welte, T.
Menzies-Gow, A.
Israel, E.
Corren, J.
Hunter, G.
Cook, W.
Colice, G.
Lanos-Ackert, P. J.
[J]. PNEUMOLOGIE, 2022, 76 : S12 - S12
[23] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Prior Omalizumab Use: A Post Hoc Analysis of the Phase 3 Navigator Study
Menzies-Gow, A.
Colice, G.
Ambrose, C. S.
Llanos, J.
Hellqvist, A.
Cook, B.
Caminati, M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[24] Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Laidlaw, Tanya M.
Menzies-Gow, Andrew
Caveney, Scott
Han, Joseph K.
Martin, Nicole
Israel, Elliot
Lee, Jason K.
Llanos, Jean-Pierre
Martin, Neil
Megally, Ayman
Parikh, Bhavini
Vong, Sylvia
Welte, Tobias
Corren, Jonathan
[J]. JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 915 - 932
[25] Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR
Menzies-Gow, Andrew
Corren, Jonathan
Israel, Elliot
Welte, Tobias
Ambrose, Christopher S.
Cook, Bill
Hunter, Gillian
Llanos-Ackert, Jean-Pierre
Colice, Gene
[J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[26] Tezepelumab Reduces Patient-reported Cough and Phlegm Production in Patients With Severe, Uncontrolled Asthma: Results From the Phase 3 NAVIGATOR Study
Castro, M.
Kraft, M.
Ambrose, C. S.
Martin, N.
Clarke, N.
Spahn, J. D.
Llanos, J.
Ponnarambil, S.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[27] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Andrew Menzies-Gow
Gene Colice
Janet M. Griffiths
Gun Almqvist
Sandhia Ponnarambil
Primal Kaur
Gennaro Ruberto
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
[J]. Respiratory Research, 21
[28] Tezepelumab Reduces Exacerbations Across All Seasons In Patients With Severe, Uncontrolled Asthma With Seasonal Allergy: Results From The Phase 3 NAVIGATOR Study
Corren, Jonathan
Lindsley, Andrew
Spahn, Joseph
Cook, Bill
Griffiths, Janet
Martin, Nicole
Colice, Gene
Pavord, Ian
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
[29] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Menzies-Gow, Andrew
Colice, Gene
Griffiths, Janet M.
Almqvist, Gun
Ponnarambil, Sandhia
Kaur, Primal
Ruberto, Gennaro
Bowen, Karin
Hellqvist, Asa
Mo, May
Garcia Gil, Esther
[J]. RESPIRATORY RESEARCH, 2020, 21 (01)
[30] On-treatment clinical remission with tezepelumab among patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study
Castro, M.
Ambrose, C. S.
Colice, G.
Roseti, S. L.
Kmita, K.
Cook, B.
Martin, N.
Llanos-Ackert, J.
Menzies-Gow, A.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60

← 1 2 3 4 5 →